Medtronic Derivative, gross, assets increased by 15.0% to $536.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 45.3%, from $980.00M to $536.00M. Over 4 years (FY 2021 to FY 2025), Derivative, gross, assets shows an upward trend with a 34.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests favorable market movements for the company's derivative positions, while a decrease indicates a decline in the value of these assets.
The current market value of derivative financial instruments that are in an asset position. This reflects the amount the...
Commonly reported by global insurers and banks; highly dependent on market interest rates and volatility.
other_derivative_fair_value_of_derivative_asset| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $102.00M | $160.00M | $254.00M | $326.00M | $695.00M | $907.00M | $1.08B | $341.00M | $368.00M | $421.00M | $720.00M | $549.00M | $659.00M | $668.00M | $589.00M | $980.00M | $334.00M | $335.00M | $466.00M | $536.00M |
| QoQ Change | — | +56.9% | +58.8% | +28.3% | +113.2% | +30.5% | +19.3% | -68.5% | +7.9% | +14.4% | +71.0% | -23.8% | +20.0% | +1.4% | -11.8% | +66.4% | -65.9% | +0.3% | +39.1% | +15.0% |
| YoY Change | — | — | — | — | +581.4% | +466.9% | +326.0% | +4.6% | -47.1% | -53.6% | -33.5% | +61.0% | +79.1% | +58.7% | -18.2% | +78.5% | -49.3% | -49.9% | -20.9% | -45.3% |